BergenBio Fundamentale Forhold (BGBIO)

anon48632287 · august 27, 2019, 7:11am

Litt over 24 kr. på meg.

Boms · august 28, 2019, 7:12am

Noen som skjønner hva som skjer? Plutselig snudd sentiment i aksjen, - 7,8% nå på morgen etter en solid nedgang i går.

Flottesen · august 28, 2019, 7:13am

Tradere som gikk inn, tradere som går ut.

Helt1 · august 28, 2019, 7:15am

Tror traderne koser seg i hele Bioteksegmentet. Masse bevegelse opp og ned.

Boms · august 28, 2019, 7:30am

Større tradere pleier vel å være forsiktig med handle for større beløp i aksjer med så dårlig likviditet.

Kanskje det er tvangssalg av en portefølje fra en overbelånt NANO aksjonær? Det hender jo at diversifiseringen er ganske dårlig blant oss norske biotek investorer. Salget nå er jo helt ukritisk, og vi har RT 14,66 - dvs 10% ned.

anon48632287 · august 28, 2019, 7:30am

Er vel ikke så rart om den skal ha en ny fot i bakken først. Det er jo typisk. Vi får se om den skal helt ned til utgangspunktet (eller om den finner støtte på den slakere mulige begynnende trend som eventuelt nå bør ligge rundt de 14,50).

Buffet · august 28, 2019, 7:34am

Bingotech-aksjene har ikke peiling hvilken retning de skal for tiden.

Tombo · august 28, 2019, 7:41am

Morgen dump, kjøp oppover dump ettermiddag

vcp · august 28, 2019, 7:45am

Bgbio ned 10% og nano opp 10%
Er nok noen som danser mellom.

Hegnar artikkelen Artic, er glemt.

Xon · august 28, 2019, 7:56am

Kanskje litt for sterke bånd mellom BgBio og Arctic … ?

vcp · august 28, 2019, 7:57am

Eneste forskjellen her, vs alt annet på børs er at det er veldig synlig.

Fornybar · august 28, 2019, 8:01am

Quotes that aged well.

TekBot · august 28, 2019, 2:32pm

BerGenBio ASA: Increase of share capital, exercise of share options and primary insider notification

Bergen, Norway, 28 August 2019. The Board of Directors of BerGenBio ASA (the
“Company”) (OSE: BGBIO) have, to fulfil the Company’s obligations under the
share option agreements and in accordance with the authorisation granted by the
…

Vis børsmeldingen

general meeting on 13 March 2019, resolved to increase the Company’s share
capital by NOK 54,000 by issuance of 540,000 new shares. The new shares are
subscribed for by option owners that wish, and are entitled, to exercise options
in accordance with the Company’s option scheme. The subscription price is in
accordance with the prevailing options price pursuant to the Company´s option
scheme, an average NOK 8.39 per share. Options which have been exercised have
been granted between 2010 and 2012 and all options will expire in 2019 if not
exercised.
Out of the total number of exercised share options, 225,000 share options at an
average strike price at NOK 8.15 were exercised by primary insider Richard
Godfrey (CEO). Richard Godfrey has transferred his rights to receive shares
resulting from the exercise of options to a third party to cover all cost
related to the exercise and will keep the remaining shares from the exercise.
The sales amount will be finally determined on the basis of the price
subsequently obtained by the third party when selling the shares in the market.
Final compensation for the transferred rights and number of shares received from
the transaction will be reported when known. After exercising options, Richard
Godfrey holds 1,129,284 unexercised options in the Company. As of today, Richard
Godfrey holds 167,815 shares in the Company through Gnist Holding AS.

Out of the total number of exercised share options, 150,000 share options at an
average strike price at NOK 8.45 were exercised by primary insider James Lorens,
CSO. James Lorens has transferred his rights to receive shares resulting from
the exercise of options to a third party to cover all cost related to the
exercise and will keep the remaining shares from the exercise. The sales amount
will be finally determined on the basis of the price subsequently obtained by
the third party when selling the shares in the market. Final compensation for
the transferred rights and number of shares received from the transaction will
be reported when known. After exercising options, James Lorens holds 588,507
unexercised options in the Company. As of today, James Lorens holds 250,000
shares in the Company.

Out of the total number of exercised share options, 15,000 share options at an
average strike price at NOK 10.62 were exercised by primary insider Endre
Kjærland, Associate Director of IP and Contracts. Endre Kjærland has transferred
his rights to receive shares resulting from the exercise of options to a third
party to cover all cost related to the exercise and will keep the remaining
shares from the exercise. The sales amount will be finally determined on the
basis of the price subsequently obtained by the third party when selling the
shares in the market. Final compensation for the transferred rights and number
of shares received from the transaction will be reported when known. After
exercising options, Endre Kjærland holds 88,525 unexercised options in the
Company. As of today, Endre Kjærland holds 1,508 shares in the Company.

The capital increase is expected to be registered within 7 days, and following
the issuance of the new shares, the issued share capital of BerGenBio ASA will
be NOK 6,107,659 consisting of 61,076,590 shares, each with a par value of NOK
0.10.

-End-

Contacts

Richard Godfrey
CEO, BerGenBio ASA
+47 917 86 304

Rune Skeie
CFO, BerGenBio ASA
rune.skeie@bergenbio.com
+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the
expectations expressed or implied in this announcement by such forward-looking
statements.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

Kilde

anon48632287 · august 28, 2019, 4:15pm

Kort om Conference on Lung Cancer som kommer 7. sept.:

“The potential of AXL inhibition will be scrutinised in presentations on Seattle Genetics/Genmab’s antibody-drug conjugate enapotamab vedotin and Bergenbio’s small molecule bemcentinib. And post-EGFR failure approaches will be on show from Merck KGaA’s tepotinib, with data relevant to Incyte and Chi Med, and Takeda/Pfizer’s TAK-788, which competes against Spectrum’s poziotinib.”

vcp · august 28, 2019, 4:57pm

Primær insiderne laster godt opp ja

drdr · august 31, 2019, 9:13pm

pdx · september 1, 2019, 10:00am

Hver måned kårer jeg det jeg kaller Teksperter™ for noen av de mest populære investeringene våre

Det er de 3 medlemmene som har fått flest likes på innleggene sine de siste 90 dagene. Teksperter™ får også en unikt merke på profilen sin og et trofé-ikon ved siden av navnet sitt. Du kan bli Tekspert™ i flere aksjer/investeringer, og troféet vil bare vises i tråder der du er Tekspert™.

Her er denne månedens Teksperter™ og det mest likte innlegget deres fra de siste 90 dagene:

@larsmkn (316 likes)

@Flottesen (82 likes)

@drdr (59 likes)

Resten av topp 10:

@anon48632287 (46 likes)
@vcp (31 likes)
@JAXI (28 likes)
@Savepig (18 likes)
@anon80503862 (18 likes)
@Morgo26 (16 likes)
@Boms (15 likes)

Gratulerer!

anon48632287 · september 2, 2019, 8:31am

Redigert: Beklager jeg blingset noe her, se rettelse fra Inkognito under!

(Listen over 20 største aksjonærer uforandret såvidt jeg kan se. ->>>Nei det har vært noen nedsalg.

https://www.bergenbio.com/investors/our-shareholders/

Inkognito666 · september 2, 2019, 8:23am

MP Pensjon solgte 500.000 og Middelborg Invest AS solgte nesten 400.000 aksjer forrige uke. Ikke utenkelig om Middelborg Invest AS forsøker kvitte seg med resterende aksjer heller (på aksjelisten pr 2.9 så har de bare 216 635 aksjer igjen).

anon48632287 · september 2, 2019, 8:30am

Hei takk for rettelse, litt pinlig fra meg! Gikk for fort her på formiddagen.

Middelborg skal vel ut ja.

Disse har også redusert litt til:
EUROCLEAR BANK S.A./N.V.